AIM
ACHC icon

Acrospire Investment Management’s Acadia Healthcare ACHC Stock Holding History

Acrospire Investment Management’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$49K – 15
2017
Q2 		$49K Buy
+1,000
New +$44.3K 0.05% 869

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acrospire Investment Management's ACHC Position: Q3 2017 in Review

Acrospire Investment Management sold out of Acadia Healthcare (ACHC) in Q3 2017, closing a stake of 1,000 shares — an estimated $49K sold.

Acrospire Investment Management first reported a position in ACHC in Q2 2017 and held it in 1 quarter. The position peaked at $49K in Q2 2017. 263 funds tracked by Wall St. Rank hold ACHC as of Q3 2017.

  • Acrospire Investment Management reported no remaining Acadia Healthcare position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,000 Acadia Healthcare shares in Q3 2017, an estimated $49K.
  • Acrospire Investment Management first reported a position in Acadia Healthcare in Q2 2017 and held it in 1 quarter.
  • Acrospire Investment Management's Acadia Healthcare position peaked at $49K in Q2 2017.
  • 263 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.